Nelly ZIADE 🍀 Nellziade
3 months 3 weeks ago
#EULAR2026 General Assembly is ON!
Record-breaking 5'705 abstracts from 102 countries
187 scientific sessions ahead
@rheumnow https://t.co/0kAqND11L7
Dr. John Cush RheumNow
3 months 3 weeks ago
RheumNow’s expanded coverage of the #EULAR2026 Annual Meeting is sponsored by Bristol Myers Squibb and UCB. RheumNow and its faculty independently select all coverage content.
A substantial portion of patients seen in rheumatology clinics are now older adults living with multimorbidity, polypharmacy, frailty, cognitive impairment, functional limitation, and competing health priorities. This week at EULAR 2026 in London, the EULAR Study Group on Geriatric Rheumatology holds its inaugural meeting. The launch marks an important step for a field that has been visible in clinical practice, but less visible in professional
Dr. John Cush RheumNow
3 months 3 weeks ago
Applying updated ACR guidelines in real life isn’t always straightforward.
Two experts share insights on managing lupus nephritis beyond the textbook.
Sponsored by Aurinia https://t.co/7NAJW3LoSM https://t.co/h5RHK290pD
Dr. John Cush RheumNow
3 months 3 weeks ago
Advanced Practice Rheum: Safety of Biologics and Novel Agents
Dr. Jack Cush reviews safety of biologics and novel agents. This video is part of the Advanced Practice Rheum series.
https://t.co/K5TiwFA0L2 https://t.co/XoFsTMnxPC
Dr. John Cush RheumNow
3 months 3 weeks ago
DERM on RheumNow PODCAST (May 2026)
The Derm on RheumNow podcast is a collection of Citations and Content curated for dermatologists – addressing Psoriasis, PsA, CLE, vasculitis, HS, and other CTD skin disorders. Dermatology drugs, biologics, JAKs - their use, efficacy, and https://t.co/0AEAxadBFT
Dr. John Cush RheumNow
3 months 3 weeks ago
Count Your Telangiectasias (5.29.2026)
Dr. Jack Cush reviews the news, journal articles and missed quiz questions.
https://t.co/KDXijQMdfr https://t.co/2Vi3MKZZbk
Dr. John Cush RheumNow
3 months 3 weeks ago
RA comorbidities are changing. ILD, anxiety, depression increasing. Less extraartic. manifestations, CA & CV dz. Consider screening for cervical CA, ILD, CV dz & OP (for pts on steroids) https://t.co/WVITFXNva7 https://t.co/tggdaO9RJB
Dr. John Cush RheumNow
3 months 3 weeks ago
Congratulations to Professor Dennis McGonagle for being awarded the prestigious Heberden Oration Award at the 2026 British Society for Rheumatology (BSR) Conference. https://t.co/TOG5Y9tNrW https://t.co/3aumO6Z3A9
Pharmaceutical companies are presenting pivotal clinical trial results and key data analyses at the EULAR 2026 Congress (June 3–6, London). Below is a summary of their most important studies — many of which are registration-enabling or will directly shape treatment decisions in rheumatic diseases.
Australia is facing a deepening rheumatology manpower crisis with direct parallels to the situation in the United States.
Dr. John Cush RheumNow
3 months 4 weeks ago
Curcumin in arthritis may have NSAID like clinical efficacy. But how? Metanalysis lays out the multiple potential effects for it to inhibit inflammatory signaling pathways (NF-κB, TNF-α, IL-1β, IL-6, COX-2, and PGE2) https://t.co/gSYVwpl41P https://t.co/0xZdyiF4QN
